Related Experiment Video
Updated: Jan 17, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Research on the function of GPX4 in tumor-targeted treatment based on its molecular structure and features
1Department of Anaesthesiology, Shenzhen Children's Hospital, Shenzhen, China.
Abstract:
GPX4 is the only antioxidant enzyme in mammals that can convert cholesterol and phospholipid hydroperoxide into phosphatidylol and cholesterol. Its peculiar molecular structure allows it to perform a variety of biological functions, including oxidative stress, ferroptosis regulation, brain development stimulation, and immune responses. In recent years, several studies have demonstrated that increased GPX4 expression is linked to tumor cell proliferation, growth, migration, and differentiation. Overexpression of GPX4 has been linked to chemoresistance and a poor prognosis in cancers including nasopharyngeal carcinoma, breast cancer, and lung cancer. GPX4 inhibitors have been demonstrated to be effective in the treatment of numerous drug-resistant malignancies. Some tumors, such as glioblastoma, do not react well to single-agent GPX4 inhibitors. Therefore, future research should focus on identifying cancers that are more responsive to GPX4 inhibitors and enhancing the efficacy of these inhibitors. This research investigates the regulatory mechanisms and properties of GPX4 in various tumor cell types, as well as its molecular structure and biological roles, hoping to propose more effective tumor-targeted therapy alternatives.
Insights
Glutathione peroxidase 4 (GPX4) is a key antioxidant enzyme involved in cell death and cancer progression. This study explores GPX4
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Glutathione peroxidase 4 (GPX4) is a unique mammalian antioxidant enzyme crucial for converting lipid hydroperoxides.
- GPX4 plays vital roles in regulating oxidative stress, ferroptosis, immune responses, and brain development.
- Elevated GPX4 expression correlates with tumor progression, proliferation, migration, differentiation, chemoresistance, and poor prognosis in various cancers.
Purpose of the Study:
- To investigate the regulatory mechanisms and properties of GPX4 in diverse tumor cell types.
- To elucidate the molecular structure and biological functions of GPX4 in cancer.
- To identify potential therapeutic strategies targeting GPX4 for improved cancer treatment.
Main Methods:
- Review and analysis of existing literature on GPX4's role in cancer.
- Investigation of GPX4's regulatory mechanisms and properties across different tumor models.
- Exploration of GPX4's molecular structure and biological functions relevant to oncogenesis.
Main Results:
- GPX4 overexpression is implicated in promoting tumor cell proliferation, migration, and chemoresistance.
- GPX4 inhibitors show efficacy against drug-resistant malignancies but limited success as single agents in some cancers like glioblastoma.
- Understanding GPX4's multifaceted roles is essential for developing targeted cancer therapies.
Conclusions:
- GPX4 is a critical determinant in cancer development and drug resistance.
- Further research is needed to identify specific cancer types responsive to GPX4 inhibitors and to enhance their therapeutic efficacy.
- Targeting GPX4 presents a promising avenue for developing novel, effective cancer treatments.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
07:44Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...